Contents

Search

gepant

Indications: - treatment of migraine attack [1] Dosage: - oral [1] Pharmacokinetics: - gepants able to cross the blood brain barrier Adverse effects: - appear to be minimal [1] Mechanism of action: - CGRP receptor antagonist - gepants do not cause vasoconstriction

Related

calcitonin gene-related peptide (CGRP)

Specific

atogepant (Qulipta) rimegepant (Nurtec ODT) ubrogepant (Ubrelvy)

General

calcitonin gene-related peptide (CGRP) inhibitor

References

  1. George J. Oral CGRP Inhibitor Helps Relieve Migraine Attack About 20% report being pain-free within 2 hours. MedPage Today. April 26, 2018 https://www.medpagetoday.com/meetingcoverage/aan/72559